Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.3000 (-2.72%) ($13.8000 - $14.8500) on Thu. Dec. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.05% (three month average) | RSI | 40 | Latest Price | $14.3000(-2.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(50%) IWO(48%) ARKK(46%) | Factors Impacting ATRA price | ATRA will decline at least -2.525% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-10%) UNG(-3%) BNDX(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.525% (StdDev 5.05%) | Hourly BBV | 0 () | Intraday Trend | -3.7% | | | |
|
1 - 5 Day Possible Target | $-1.77(-112.38%) | Resistance Level | $16.53 | 5 Day Moving Average | $14.86(-3.77%) | 10 Day Moving Average | $15.44(-7.38%) | 20 Day Moving Average | $16.53(-13.49%) | To recent high | -33.1% | To recent low | 11.7% | Market Cap | $1.063b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |